Any current/future new fundraising through debt or equity?

There is no specific mention of any current or planned new fundraising through debt or equity in the transcript. The company is focused on gradual reduction of debt and prioritizes growth investments. Debt and interest costs may fluctuate due to phasing and accelerated CAPEX but no fresh fundraising is indicated. Management emphasizes sustained double-digit revenue growth funded by internal resources. M&A opportunities are being actively pursued, but no concrete plans or fundraising linked to M&A were disclosed.

Any current/future capex/capital investment/strategic investment?

EPL Limited is actively investing in extruded capacity, particularly in the Beauty & Cosmetics (B&C) segment, to support high growth. A new manufacturing plant in Thailand was commercialized recently (November of the reported quarter) and is currently scaling up. The company follows an investment philosophy of aligning capital expenditure with depreciation, ensuring depreciation growth remains lower than revenue growth. They continue to make capital investments that support sustainable double-digit revenue growth and margin expansion. EPL is building front-end and back-end capabilities, includ

Future growth expectations in sales/revenue/volumes?

EPL Limited expects sustained double-digit revenue growth over the next 5 years. Beauty & Cosmetics segment is targeted to grow at a high teen percentage rate, reflecting significant headroom and strategic focus. Oral care and pharma segments are expected to grow steadily but at a comparatively moderate pace. Continuous investments in innovation, extruded capacity, and front-end/back-end capabilities support this growth trajectory. Emerging markets like Thailand and Brazil are key growth drivers, with organic scaling expected in Thailand. The company remains open to M&A opportunities

Future growth expectations in earnings/operating earnings/profits/EPS?

EPL Limited expects sustained double-digit revenue growth over the next 5 years (Page 16). Beauty & Cosmetics segment targeted for high teen percentage growth in topline (Page 16). EBITDA growth anticipated to be slightly ahead of revenue growth, emphasizing margin improvement (Pages 10, 14). ROCE targets an expansion from 18% to 25%, driven by both margin improvement and capital efficiency (Page 14). The company prioritizes growth over other metrics but aims to grow EBITDA slightly ahead of revenue (Page 14). Proactive margin management processes have been implemented to protect margins amid

Current/ Expected Orderbook/ Pending Orders?

The transcript does not provide specific details on the current or expected order book or pending orders for EPL Limited. However, Hemant Bakshi mentioned a "really strong and healthy pipeline" of business in Thailand, indicating promising future orders in that geography. The company is focused on scaling up operations in new markets like Thailand, though commercial operations there started recently. The management highlighted ongoing efforts to acquire and retain customers, especially in the Beauty & Cosmetics segment, which has many more customers compared to Oral care. Growth and order infl

IN US

Sale is live|00:00:00left today

EPL LtdQ4 FY27Industrial Products

EPL Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹229P/E: 17.5Market Cap: ₹7.2K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→EPL Limited expects sustained double-digit revenue growth over the next 5 years.
→Beauty & Cosmetics segment is targeted to grow at a high teen percentage rate, reflecting significant headroom and strategic focus.
→Oral care and pharma segments are expected to grow steadily but at a comparatively moderate pace.
→Continuous investments in innovation, extruded capacity, and front-end/back-end capabilities support this growth trajectory.
→Emerging markets like Thailand and Brazil are key growth drivers, with organic scaling expected in Thailand.
→The company remains open to M&A opportunities that extend geographic reach or build new capabilities aligned with growth and margin accretion.
→Overall, ESL aims to prioritize growth over other metrics, targeting EBITDA growth slightly ahead of revenue growth.
→The goal includes strengthening market share, especially in Beauty & Cosmetics, and achieving operational efficiencies contributing to growth.

Margin guidance

Category 2

→EPL Limited expects sustained double-digit revenue growth over the next 5 years (Page 16).
→Beauty & Cosmetics segment targeted for high teen percentage growth in topline (Page 16).
→EBITDA growth anticipated to be slightly ahead of revenue growth, emphasizing margin improvement (Pages 10, 14).
→ROCE targets an expansion from 18% to 25%, driven by both margin improvement and capital efficiency (Page 14).
→The company prioritizes growth over other metrics but aims to grow EBITDA slightly ahead of revenue (Page 14).
→Proactive margin management processes have been implemented to protect margins amid commodity cycles (Page 16).
→Margin expansion initiatives and operational efficiencies are ongoing, especially in Europe, aiming to return to mid-teen margins (Page 9).
→The overall strategy is focused on profitable, sustainable growth with strong cash flow and ROCE improvement (Page 5).

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no specific mention of any current or planned new fundraising through debt or equity in the transcript.
→The company is focused on gradual reduction of debt and prioritizes growth investments.
→Debt and interest costs may fluctuate due to phasing and accelerated CAPEX but no fresh fundraising is indicated.
→Management emphasizes sustained double-digit revenue growth funded by internal resources.
→M&A opportunities are being actively pursued, but no concrete plans or fundraising linked to M&A were disclosed.

Order book

→The transcript does not provide specific details on the current or expected order book or pending orders for EPL Limited.
→However, Hemant Bakshi mentioned a "really strong and healthy pipeline" of business in Thailand, indicating promising future orders in that geography.
→The company is focused on scaling up operations in new markets like Thailand, though commercial operations there started recently.
→The management highlighted ongoing efforts to acquire and retain customers, especially in the Beauty & Cosmetics segment, which has many more customers compared to Oral care.
→Growth and order inflows appear strong in Beauty & Cosmetics and China regions, reflecting positive demand momentum.
→No quantitative figures or specific order backlog numbers were disclosed in the transcript.

Capex plans

Yes

→EPL Limited is actively investing in extruded capacity, particularly in the Beauty & Cosmetics (B&C) segment, to support high growth.
→A new manufacturing plant in Thailand was commercialized recently (November of the reported quarter) and is currently scaling up.
→The company follows an investment philosophy of aligning capital expenditure with depreciation, ensuring depreciation growth remains lower than revenue growth.
→They continue to make capital investments that support sustainable double-digit revenue growth and margin expansion.
→EPL is building front-end and back-end capabilities, including a center of excellence in Mumbai focused on innovation, proofing, and sampling.
→The company is exploring M&A opportunities that offer new geographical presence or new capabilities, with criteria focusing on margin and growth accretiveness, although no concrete deals are currently announced.
→Overall, EPL prioritizes growth investments while maintaining margin discipline and capital efficiency.

How does EPL Ltd rank vs peers in Industrial Products?

Pro feature

1EPL Ltd

Rev 3Mar 2

See full Industrial Products sector rankings

Want more stocks like EPL Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio